Use of novel oral anticoagulant agents in venous thromboembolism

被引：16

作者：

Madan, Shivanshu ^{[1
]}

Shah, Shenil ^{[2
]}

Dale, Patrick ^{[3
]}

Partovi, Sasan ^{[4
]}

Parikh, Sahil A. ^{[5
,6
,7
]}

机构：

[1] Univ North Carolina Hosp, Dept Cardiovasc Med, Chapel Hill, NC USA

[2] Univ Wisconsin, Dept Cardiovasc Med, Madison, WI USA

[3] Univ North Carolina Hosp, Dept Internal Med, Chapel Hill, NC USA

[4] Univ Hosp Cleveland, Dept Radiol, Med Ctr, 2074 Abington Rd, Cleveland, OH 44106 USA

[5] Columbia Univ, Med Ctr, Ctr Intervent Vasc Therapy, 161 Ft Washington Ave,6th Floor, New York, NY 10032 USA

[6] Columbia Univ, Med Ctr, Div Cardiol, Dept Med, 161 Ft Washington Ave,6th Floor, New York, NY 10032 USA

[7] Columbia Univ Coll Phys & Surg, 161 Ft Washington Ave,6th Floor, New York, NY 10032 USA

来源：

CARDIOVASCULAR DIAGNOSIS AND THERAPY | 2016年 / 6卷 / 06期

关键词：

Warfarin; dabigatran; apixaban; rivaroxaban; edoxaban; deep vein; thrombosis; pulmonary embolism (PE); FACTOR-XA INHIBITOR; VITAMIN-K ANTAGONIST; ATRIAL-FIBRILLATION; KNEE REPLACEMENT; DABIGATRAN ETEXILATE; COST-EFFECTIVENESS; ENOXAPARIN PLUS; IN-VITRO; RIVAROXABAN; THROMBOPROPHYLAXIS;

D O I：

10.21037/cdt.2016.11.17

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

New oral anticoagulants (NOAC) serve as alternatives for patients currently using warfarin for the prevention and treatment of venous thromboembolic (VTE) disease. This article provides a brief summary of the clinical use of these drugs as well as a review of the landmark clinical trials which evaluated described their safety and efficacy. As more data becomes available, a fundamental understanding of these medications will be vital to cardiovascular practitioners managing patients with VTE.

引用

页码：570 / 581

页数：12

共 49 条

[11] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[12] Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation-Quality and Cost Implications [J].

Desai, Nihar R. ;

Krumme, Alexis A. ;

Schneeweiss, Sebastian ;

Shrank, William H. ;

Brill, Gregory ;

Pezalla, Edmund J. ;

Spettell, Claire M. ;

Brennan, Troyen A. ;

Matlin, Olga S. ;

Avorn, Jerry ;

Choudhry, Niteesh K. .

AMERICAN JOURNAL OF MEDICINE, 2014, 127 (11) :1075-+

[13] Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial [J].

Eriksson, B. I. ;

Dahl, O. E. ;

Rosencher, N. ;

Kurth, A. A. ;

Van Dijk, N. ;

Frostick, S. P. ;

Kalebo, P. ;

Christiansen, A. V. ;

Hantel, S. ;

Hettiarachchi, R. ;

Schnee, J. ;

Buller, H. R. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (11) :2178-2185

[14] Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty [J].

Eriksson, Bengt I. ;

Borris, Lars C. ;

Friedman, Richard J. ;

Haas, Sylvia ;

Huisman, Menno V. ;

Kakkar, Ajay K. ;

Bandel, Tiemo J. ;

Beckmann, Horst ;

Muehlhofer, Eva ;

Misselwitz, Frank ;

Geerts, William .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) :2765-2775

[15] ORAL ANTICOAGULANTS - PHARMACODYNAMICS, CLINICAL INDICATIONS AND ADVERSE-EFFECTS [J].

FREEDMAN, MD .

JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (03) :196-209

[16] Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents [J].

Fukuda, Toshio ;

Honda, Yuko ;

Kamisato, Chikako ;

Morishima, Yoshiyuki ;

Shibano, Toshiro .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) :253-259

[17] DU-176b, a potent and orally active factor Xa inhibitor:: in vitro and in vivo pharmacological profiles [J].

Furugohri, T. ;

Isobe, K. ;

Honda, Y. ;

Kamisato-Matsumoto, C. ;

Sugiyama, N. ;

Nagahara, T. ;

Morishima, Y. ;

Shibano, T. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (09) :1542-1549

[18] Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery [J].

Ginsberg, Jeffrey S. ;

Davidson, Bruce L. ;

Comp, Philip C. ;

Francis, Charles W. ;

Friedman, Richard J. ;

Hue, Michael H. ;

Lieberman, Jay R. ;

Muntz, James E. ;

Raskob, Gary E. ;

Clements, Mary L. ;

Hentel, Stefan ;

Schnee, Janet M. ;

Caprini, Joseph A. .

JOURNAL OF ARTHROPLASTY, 2009, 24 (01) :1-9

[19] New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons [J].

Hirschl, Mirko ;

Kundi, Michael .

VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2014, 43 (05) :353-364

[20] Systematic overview of warfarin and its drug and food interactions [J].

Holbrook, AM ;

Pereira, JA ;

Labiris, R ;

McDonald, H ;

Douketis, JD ;

Crowther, M ;

Wells, PS .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1095-1106

← 1 2 3 4 5 →